XRNChiron Real Estate Inc.

$29.97-1.5% 1Y

Is the price fair?

Good

Cheap against its own history. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 good, 2 without data
Vs its own P/E rangecheapest in 22 quartersderived

Cheap vs its own history: P/E 8.1 vs a 39.4 median over 22 quarters (−79% vs median).

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What XRN's price assumes

Chiron Real Estate Inc. trades at 8.08× earnings against 38.9× for the median REIT - Healthcare Facilities name, cheaper than its own group.

8.08

Trailing P/E · REIT - Healthcare Facilities median 38.9 · cheaper than the typical name in its group

Price / sales
3.23

Price / sales · as of 2026-Q2

Price / book
0.76

Price / book · as of 2026-Q2

Details›
Price / bookas of 2026-Q2
0.76
Real Estate median P/E130 names
26.0
REIT - Healthcare Facilities median P/E11 names
38.9
Market capitalisation13.2 million shares, counted Aug 3, 2026
$397M
XRN has re-rated away from its own history, so multiplying the old multiple by today's earnings prices a full reversal, not the business
MethodPer share
What its own history would implynot meaningful, 8.08× today against a 39.4× median
52-week range$28.75 – $38.09
Today$29.97

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

Against its own past

Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.